HyaFilia

Featured

Indications:

Nasolabial folds — filling and softening without an “overloaded” effect. Marionette lines — restoring the corners of the mouth, gentle lifting of the perioral area. Lip contour and volume — clear yet natural definition. Middle third of the face — compensating moderate volume loss. Tear trough (naso-jugal groove). Chin area and facial oval — gentle modelling and symmetry. Cheek area — increasing firmness and lifting. Reduction of scar visibility.

Compound:

COMPOSITION:

Hyaluronic Acid — two fractions:
– 85% stabilised (cross-linked) hyaluronic acid
– 15% non-stabilised (free) hyaluronic acid

This unique combination gives the filler excellent plasticity, uniform distribution in tissues and easy injection. Post-procedural massage is not always required — the gel naturally positions itself correctly in the tissues.

Lidocaine — included in the formula for maximum patient comfort during the procedure.

Origin: non-animal — the risk of allergic reactions is reduced to zero.

SAFETY PARAMETERS:
Residual BDDE: < 0.5 ppm (undetectable).
Endotoxins: < 0.25 EU/ml.
Technology: CHA-HEART (High-concentration Emulsion Arrangement & Reaction Technology).
Extrusion force: 12 N.
High resistance to hyaluronidase and free radicals.

Volume:

1 ml

Manufacturer:

CHA Meditech Co., Ltd. (South Korea)

Recommended course:

Duration of effect: 6–14 months (depending on individual metabolism, age and lifestyle). Maintenance procedure: every 6–14 months, depending on the treated area and individual characteristics. Injection levels: superficial and mid-layers of the dermis. Working method: soft, controlled injection — with needle or cannula. Procedure duration: 30–60 minutes. CONTRAINDICATIONS: – Individual intolerance to the components of the composition – Infectious-inflammatory processes, open wounds in the injection area – Age under 18 years – Haemophilia – Oncology – Diabetes mellitus and other chronic diseases in the decompensation stage – Pregnancy and breastfeeding – Acute infectious diseases For professional use only — physicians and qualified medical aesthetics specialists.

Price:

Find out the price

HYAFILIA is a premium hybrid hyaluronic acid filler range produced by CHA Meditech Co., Ltd. (South Korea), designed for delicate corrections and natural results. The unique formula combines 85% stabilised (cross-linked) and 15% non-stabilised (free) hyaluronic acid — giving the gel excellent plasticity, uniform distribution in tissues and easy injection. The gel naturally positions itself correctly without always requiring post-procedural massage. Of non-animal origin, HYAFILIA virtually eliminates the risk of allergic reactions. High resistance to hyaluronidase and free radicals ensures a lasting effect of 6 to 14 months. The exclusive CHA-HEART technology provides a homogeneous structure, undetectable residual BDDE (< 0.5 ppm) and endotoxins < 0.25 EU/ml — maximum safety even in delicate areas. A clinical study published by the Korean Society of Plastic & Reconstructive Surgeons (Vol. 38, No. 1) confirms efficacy comparable to Restylane, high biocompatibility and minimal inflammatory reactions.

HYAFILIA works on two levels: 1. HYDRATION AND VOLUME RESTORATION The combination of 85% stabilised + 15% non-stabilised hyaluronic acid distributes the gel uniformly in tissues, restoring lost volume and providing deep, long-lasting dermal hydration. The free fraction delivers immediate hydration, while the cross-linked fraction ensures stability and longevity. 2. LIFTING AND NATURAL MODELLING The homogeneous particle structure and high gel elasticity give the physician precise control — no overfilling, no migration, with a natural and predictable result. Resistance to hyaluronidase and free radicals maintains the effect for 6–14 months.

– Exclusive formula: 85% stabilised HA + 15% non-stabilised HA — maximum plasticity and naturalness – CHA-HEART technology — ideal texture and homogeneous gel structure – Undetectable residual BDDE < 0.5 ppm — maximum safety – Endotoxins < 0.25 EU/ml – Extrusion force 12 N — easy injection, no hand fatigue – Effect: 6–14 months — high resistance to hyaluronidase and free radicals – Contains lidocaine — maximum patient comfort – Non-animal origin — allergic reaction risk reduced to zero – Post-procedural massage not always required — gel distributes naturally – No gel migration — predictable and controlled result – Clinically proven efficacy: comparable to Restylane (WSRS < 0.001) – High biocompatibility, minimal inflammatory reactions – Minimal swelling and rapid recovery – Produced by CHA Meditech Co., Ltd. — global leader in injectable cosmetology

What makes HYAFILIA different from other HA fillers?

The unique formula of 85% stabilised + 15% non-stabilised HA gives excellent plasticity and uniform distribution. The gel naturally positions itself correctly in tissues without always requiring post-procedural massage.

Does it contain lidocaine?

Yes, HYAFILIA contains lidocaine for maximum patient comfort during the procedure.

How long does the effect last?

6–14 months, depending on individual metabolism, age and lifestyle.

Is it safe for allergy-prone patients?

Yes, HYAFILIA is of non-animal origin, which virtually eliminates the risk of allergic reactions.

What are the main contraindications?

Intolerance to components, active inflammation in the injection area, pregnancy, breastfeeding, age under 18, haemophilia, oncology, acute illnesses.

Which areas is it recommended for?

Nasolabial folds, marionette lines, lips, tear trough, middle third, chin, cheeks, scar reduction.

Who can perform the procedure?

Physicians and qualified medical aesthetics specialists only.